logo
Select company
Select metric
-290.75%EBITDA Margin
VS
Market
8
Sector
29
Industry
52
History
14
$ 8.01Close
$ 1.9 - $ 14.3 52-Week Range
Ticker Information

Ticker

CRVO

Company Name

CERVOMED INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CERVOMED INC - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CRVO - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -22.61M-290.75%$ 7.78M
3/31/2025$ -18.67M-200.58%$ 9.31M
12/31/2024$ -16.29M-167.29%$ 9.74M
9/30/2024$ -11.95M-118.68%$ 10.07M
6/30/2024$ -5.04M-52.24%$ 9.65M
3/31/2024$ -4.84M-76.04%$ 6.36M
12/31/2023$ -2.17M-30.4%$ 7.14M
9/30/2023$ -8.13M-532.67%$ 1.53M
6/30/2023$ -13.08M0%$ 0
3/31/2023$ -15.16M0%$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CERVOMED INC's latest trailing twelve months (TTM) EBITDA % stands at 0%.
  • Over the past 5 years, CERVOMED INC's average EBITDA % has been -183.58%.
  • The median EBITDA % for CERVOMED INC during this period was -142.99%
  • CERVOMED INC reached its highest EBITDA % over the past 5 years at -30.4%.
  • The lowest EBITDA % recorded by CERVOMED INC in the same timeframe -532.67%

CERVOMED INC's EBITDA % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA % Benchmarks
CompanyEBITDA %
TCRX : TSCAN THERAPEUTICS INC -1875.46%FATE : FATE THERAPEUTICS INC -1835.79%CUE : CUE BIOPHARMA INC -435.19%SRZN : SURROZEN INC -298.74%OVID : OVID THERAPEUTICS INC -548.31%ARMP : ARMATA PHARMACEUTICALS INC -253.28%CBUS : CIBUS INC -4841.29%VERU : VERU INC -479.21%PSTV : PLUS THERAPEUTICS INC -274.01%ORMP : ORAMED PHARMACEUTICALS INC -1743.8%

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for CERVOMED INC is calculated as follows: EBITDA [ $ -14.71M ] / Revenues [ $ 0 ]
(=) EBITDA % [ 0% ]

CRVO - EBITDA Margin, Last 5 years

-532.67%

Minimum

Sep 30, 2023

-30.4%

Maximum

Dec 31, 2023

-183.58%

Average

-142.99%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-74.33%
max97.24%
average16.2%
median14.74%
std26.73%